Aspira Women's Health Inc. (AWH)
USD 0.77
(1.97%)
USD 0.77
(1.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 24.11 Million USD | -40.68% |
| 2022 | 37.08 Million USD | 4.0% |
| 2021 | 35.65 Million USD | 85.55% |
| 2020 | 19.21 Million USD | 16.66% |
| 2019 | 16.47 Million USD | 46.5% |
| 2018 | 11.24 Million USD | 5.6% |
| 2017 | 10.64 Million USD | -28.53% |
| 2016 | 14.89 Million USD | -22.07% |
| 2015 | 19.11 Million USD | -6.76% |
| 2014 | 20.5 Million USD | 82.09% |
| 2013 | 11.25 Million USD | -1.04% |
| 2012 | 11.37 Million USD | -41.46% |
| 2011 | 19.43 Million USD | 23.88% |
| 2010 | 15.68 Million USD | 192.54% |
| 2009 | 5.36 Million USD | -63.31% |
| 2008 | 14.61 Million USD | -25.56% |
| 2007 | 19.63 Million USD | -29.3% |
| 2006 | 27.77 Million USD | -42.21% |
| 2005 | 48.06 Million USD | -19.6% |
| 2004 | 59.78 Million USD | -9.98% |
| 2003 | 66.4 Million USD | 16.68% |
| 2002 | 56.91 Million USD | 35.94% |
| 2001 | 41.86 Million USD | 9.0% |
| 2000 | 38.4 Million USD | 190.21% |
| 1999 | 13.23 Million USD | 35.41% |
| 1998 | 9.77 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.81 Million USD | -1.86% |
| 2024 Q1 | 5.92 Million USD | 10.65% |
| 2023 Q3 | 5.42 Million USD | -7.63% |
| 2023 Q1 | 6.96 Million USD | 1.8% |
| 2023 FY | 24.11 Million USD | -34.97% |
| 2023 Q2 | 5.87 Million USD | -15.65% |
| 2023 Q4 | 5.35 Million USD | -1.27% |
| 2022 Q3 | 10.85 Million USD | 18.15% |
| 2022 Q2 | 9.18 Million USD | -10.01% |
| 2022 Q1 | 10.2 Million USD | 2.49% |
| 2022 FY | 37.08 Million USD | 4.0% |
| 2022 Q4 | 6.83 Million USD | -37.0% |
| 2021 Q3 | 10.44 Million USD | 19.07% |
| 2021 Q1 | 6.48 Million USD | 2.92% |
| 2021 Q4 | 9.96 Million USD | -4.6% |
| 2021 Q2 | 8.76 Million USD | 35.12% |
| 2021 FY | 35.65 Million USD | 85.55% |
| 2020 Q3 | 4.71 Million USD | 18.45% |
| 2020 Q2 | 3.97 Million USD | -5.71% |
| 2020 FY | 19.21 Million USD | 16.66% |
| 2020 Q1 | 4.22 Million USD | 7.65% |
| 2020 Q4 | 6.3 Million USD | 33.78% |
| 2019 Q3 | 4.18 Million USD | -7.78% |
| 2019 FY | 16.47 Million USD | 46.5% |
| 2019 Q2 | 4.53 Million USD | 18.57% |
| 2019 Q1 | 3.82 Million USD | 27.9% |
| 2019 Q4 | 3.92 Million USD | -6.35% |
| 2018 Q3 | 2.63 Million USD | -9.96% |
| 2018 Q4 | 2.99 Million USD | 13.41% |
| 2018 FY | 11.24 Million USD | 5.6% |
| 2018 Q1 | 2.68 Million USD | -11.34% |
| 2018 Q2 | 2.93 Million USD | 9.32% |
| 2017 Q3 | 2.41 Million USD | -5.14% |
| 2017 Q2 | 2.55 Million USD | -3.95% |
| 2017 Q1 | 2.65 Million USD | -7.52% |
| 2017 FY | 10.64 Million USD | -28.53% |
| 2017 Q4 | 3.02 Million USD | 25.01% |
| 2016 Q3 | 3.27 Million USD | -15.76% |
| 2016 Q1 | 4.87 Million USD | 0.06% |
| 2016 Q2 | 3.88 Million USD | -20.32% |
| 2016 Q4 | 2.87 Million USD | -12.23% |
| 2016 FY | 14.89 Million USD | -22.07% |
| 2015 FY | 19.11 Million USD | -6.76% |
| 2015 Q4 | 4.87 Million USD | 3.27% |
| 2015 Q3 | 4.71 Million USD | -1.93% |
| 2015 Q2 | 4.8 Million USD | 1.84% |
| 2015 Q1 | 4.72 Million USD | -8.44% |
| 2014 Q2 | 5.79 Million USD | 36.49% |
| 2014 Q3 | 5.3 Million USD | -8.42% |
| 2014 FY | 20.5 Million USD | 82.09% |
| 2014 Q4 | 5.15 Million USD | -2.81% |
| 2014 Q1 | 4.24 Million USD | 27.25% |
| 2013 Q1 | 2.89 Million USD | 21.0% |
| 2013 Q3 | 2.62 Million USD | 8.89% |
| 2013 Q2 | 2.4 Million USD | -16.76% |
| 2013 Q4 | 3.33 Million USD | 27.23% |
| 2013 FY | 11.25 Million USD | -1.04% |
| 2012 Q4 | 2.39 Million USD | -7.47% |
| 2012 Q2 | 3.96 Million USD | 62.59% |
| 2012 FY | 11.37 Million USD | -41.46% |
| 2012 Q1 | 2.43 Million USD | -37.71% |
| 2012 Q3 | 2.58 Million USD | -34.81% |
| 2011 Q4 | 3.91 Million USD | -18.81% |
| 2011 Q1 | 4.83 Million USD | 6.59% |
| 2011 Q3 | 4.82 Million USD | -17.79% |
| 2011 Q2 | 5.86 Million USD | 21.26% |
| 2011 FY | 19.43 Million USD | 23.88% |
| 2010 Q4 | 4.53 Million USD | 13.43% |
| 2010 Q3 | 4 Million USD | -1.84% |
| 2010 Q2 | 4.07 Million USD | 32.43% |
| 2010 Q1 | 3.07 Million USD | 105.13% |
| 2010 FY | 15.68 Million USD | 192.54% |
| 2009 Q3 | 692 Thousand USD | -33.65% |
| 2009 FY | 5.36 Million USD | -63.31% |
| 2009 Q4 | 1.5 Million USD | 116.76% |
| 2009 Q2 | 1.04 Million USD | -50.99% |
| 2009 Q1 | 2.12 Million USD | -39.36% |
| 2008 Q1 | 4.59 Million USD | 40.39% |
| 2008 FY | 14.61 Million USD | -25.56% |
| 2008 Q2 | 3.4 Million USD | -25.81% |
| 2008 Q3 | 3.1 Million USD | -8.95% |
| 2008 Q4 | 3.5 Million USD | 13.05% |
| 2007 Q2 | 5.91 Million USD | 4.36% |
| 2007 Q1 | 5.66 Million USD | 614.25% |
| 2007 FY | 19.63 Million USD | -29.3% |
| 2007 Q4 | 3.27 Million USD | -31.64% |
| 2007 Q3 | 4.78 Million USD | -19.0% |
| 2006 Q2 | 9.54 Million USD | 8.82% |
| 2006 Q1 | 8.77 Million USD | -32.0% |
| 2006 Q3 | 8.65 Million USD | -9.31% |
| 2006 Q4 | 793 Thousand USD | -90.84% |
| 2006 FY | 27.77 Million USD | -42.21% |
| 2005 FY | 48.06 Million USD | -19.6% |
| 2005 Q1 | 12.28 Million USD | 47.84% |
| 2005 Q3 | 10.71 Million USD | -11.88% |
| 2005 Q4 | 12.9 Million USD | 20.4% |
| 2005 Q2 | 12.16 Million USD | -1.01% |
| 2004 Q2 | 18.23 Million USD | 5.39% |
| 2004 Q1 | 17.3 Million USD | 3.05% |
| 2004 Q3 | 15.93 Million USD | -12.62% |
| 2004 FY | 59.78 Million USD | -9.98% |
| 2004 Q4 | 8.3 Million USD | -47.85% |
| 2003 Q2 | 17.56 Million USD | 2.43% |
| 2003 Q4 | 16.79 Million USD | 12.62% |
| 2003 Q1 | 17.14 Million USD | 2.79% |
| 2003 Q3 | 14.91 Million USD | -15.1% |
| 2003 FY | 66.4 Million USD | 16.68% |
| 2002 Q3 | 14.96 Million USD | 11.74% |
| 2002 Q4 | 16.68 Million USD | 11.46% |
| 2002 FY | 56.91 Million USD | 35.94% |
| 2002 Q1 | 11.87 Million USD | -8.93% |
| 2002 Q2 | 13.39 Million USD | 12.79% |
| 2001 Q1 | 9.08 Million USD | -18.69% |
| 2001 FY | 41.86 Million USD | 9.0% |
| 2001 Q4 | 13.03 Million USD | 28.17% |
| 2001 Q3 | 10.17 Million USD | 6.36% |
| 2001 Q2 | 9.56 Million USD | 5.24% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | 11.17 Million USD | 48.13% |
| 2000 Q3 | 7.54 Million USD | 0.0% |
| 2000 FY | 38.4 Million USD | 190.21% |
| 1999 FY | 13.23 Million USD | 35.41% |
| 1998 FY | 9.77 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | 83.815% |
| Prenetics Global Limited | 60.73 Million USD | 60.297% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -48.193% |
| CareDx, Inc | 277.76 Million USD | 91.319% |
| Exact Sciences Corporation | 2.06 Billion USD | 98.83% |
| Exagen Inc. | 52.29 Million USD | 53.887% |
| Inotiv, Inc. | 246.9 Million USD | 90.233% |
| Guardant Health, Inc. | 901.62 Million USD | 97.325% |
| Biodesix, Inc. | 77.41 Million USD | 68.853% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -514.669% |
| Precipio, Inc. | 13.63 Million USD | -76.815% |
| iSpecimen Inc. | 16.27 Million USD | -48.145% |
| Natera, Inc. | 938.98 Million USD | 97.432% |
| Standard BioTools Inc. | 113.48 Million USD | 78.752% |
| 23andMe Holding Co. | 420.73 Million USD | 94.269% |
| Castle Biosciences, Inc. | 242.78 Million USD | 90.068% |
| Personalis, Inc. | 128.14 Million USD | 81.182% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | 78.182% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -46.263% |
| OpGen, Inc. | 30.65 Million USD | 21.345% |
| T2 Biosystems, Inc. | 41.49 Million USD | 41.886% |
| Myriad Genetics, Inc. | 600.1 Million USD | 95.982% |
| ICON Public Limited Company | 755.64 Million USD | 96.809% |
| NeoGenomics, Inc. | 341.25 Million USD | 92.934% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -48.193% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 97.793% |
| RadNet, Inc. | 268.87 Million USD | 91.032% |
| MDxHealth SA | 71.25 Million USD | 66.159% |
| Psychemedics Corporation | 11.33 Million USD | -112.758% |
| Illumina, Inc. | 3.81 Billion USD | 99.368% |
| Check-Cap Ltd. | 19.28 Million USD | -25.027% |
| Twist Bioscience Corporation | 354.18 Million USD | 93.192% |
| DarioHealth Corp. | 62.17 Million USD | 61.215% |
| Fulgent Genetics, Inc. | 171.9 Million USD | 85.973% |
| Sera Prognostics, Inc. | 39.91 Million USD | 39.59% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -129.205% |
| OPKO Health, Inc. | 574.68 Million USD | 95.804% |
| Medpace Holdings, Inc. | 187.68 Million USD | 87.152% |
| Neogen Corporation | 405.23 Million USD | 94.049% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -105.948% |
| Prenetics Global Limited | 60.73 Million USD | 60.297% |
| Mainz Biomed B.V. | 27.15 Million USD | 11.197% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -175.122% |
| Trinity Biotech plc | 46.49 Million USD | 48.136% |
| Neuronetics, Inc. | 82.25 Million USD | 70.685% |
| Sotera Health Company | 300.46 Million USD | 91.974% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -175.122% |